Cite
HARVARD Citation
Necchi, A. et al. (n.d.). Clinical significance of early circulating tumor cells (CTC) changes, analyzed by AdnaTest, in patients (pts) receiving first-line methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy (CT) for metastatic urothelial cancer (UC). European journal of cancer. pp. S45-S46. [Online].